- Home
- NDRA
as 07-26-2024 4:00pm EST
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | ANN ARBOR |
| Market Cap: | 6.5M | IPO Year: | 2017 |
| Target Price: | $8.00 | AVG Volume (30 days): | 7.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.07 - $2.79 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 700.00% |
Latest ENDRA Life Sciences Inc. News
NDRA Breaking Stock News: Dive into NDRA Ticker-Specific Updates for Smart Investing
MT Newswires
2 months ago
Top Midday Decliners
Business Wire
2 months ago
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
Business Wire
2 months ago
ENDRA Provides Update Following In-person Meeting with FDA
GuruFocus.com
2 months ago
ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Business Wire
2 months ago
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
Business Wire
3 months ago
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
Business Wire
3 months ago
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
Insider Monkey
4 months ago
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript
Compare NDRA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NDRA ENDRA Life Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.